Geriatric Oncology

Top Story

Adoption of stereotactic body radiation therapy improves OS in elderly patients with NSCLC

Adoption of stereotactic body radiation therapy improves OS in elderly patients with NSCLC
September 27, 2016

The widespread adoption of stereotactic body radiation therapy to treat elderly patients with early-stage non–small cell lung cancer has improved survival rates, according to retrospective, population-based study results presented at the ASTRO Annual Meeting.

Stereotactic body radiation therapy — which delivers highly targeted, escalated radiation in one to five sessions — has become the standard of care for patients with inoperable early-stage NSCLC. In particular, its adoption has increased in elderly patients, who often have comorbidities that limit surgical options.

Perspective

AACR report: Sustained federal commitment required to accelerate cancer research progress

September 20, 2016
Extraordinary therapeutic advances, a renewed bipartisan commitment to medical research and the launch of the national cancer moonshot initiative have reinforced the…

Biden announces steps to improve clinical trials under cancer moonshot

September 19, 2016
Vice President Joe Biden outlined a plan to improve the efficiency and transparency of the U.S. clinical research system as part of the national cancer moonshot…

Blue ribbon panel presents research road map for cancer moonshot initiative

September 7, 2016
The national cancer moonshot initiative’s blue ribbon panel delivered 10 recommendations to form a 5-year research blueprint to accelerate progress against cancer…
CME

The Patient with Castration-resistant Prostate Cancer

No commercial support for this activity.

Castration-resistant prostate cancer (CRPC) is a heterogeneous condition that encompasses a continuum of disease…
More »
Video
Meeting News Coverage

VIDEO: CPX-351 improves outcomes for elderly patients with high-risk AML

June 20, 2016
More »
Featured
At Issue: Breast Cancer Resource Center

At Issue: Breast Cancer Resource Center

CME

The Patient with Severe Leukocytosis

No commercial support for this activity.

Currently five tyrosine kinase inhibitors are available for use in patients with chronic myeloid leukemia (CML)…
More »
Meeting News Coverage

Adoption of stereotactic body radiation therapy improves OS in elderly patients with NSCLC

September 27, 2016
The widespread adoption of stereotactic body radiation therapy to treat elderly patients with early-stage non–small cell lung cancer has…

Perspective

AACR report: Sustained federal commitment required to accelerate cancer research progress

September 20, 2016
Extraordinary therapeutic advances, a renewed bipartisan commitment to medical research and the launch of the national cancer moonshot initiative…

Biden announces steps to improve clinical trials under cancer moonshot

September 19, 2016
Vice President Joe Biden outlined a plan to improve the efficiency and transparency of the U.S. clinical research system as part of the national…

Blue ribbon panel presents research road map for cancer moonshot initiative

September 7, 2016
The national cancer moonshot initiative’s blue ribbon panel delivered 10 recommendations to form a 5-year research blueprint to accelerate…

In the Journals Plus

Genetic risk factors, family history predict venous thrombosis in older patients

September 2, 2016
Genetic factors that predicted venous thrombosis in younger patients remained predictive in older cohorts, according to results of a…

ASTRO Annual Meeting to reflect theme of ‘enhancing value, improving outcomes’

August 18, 2016
The American Society for Radiation Oncology will hold its annual meeting from Sept. 25 to 28 in Boston. More than 10,000 people are expected to…

In the Journals Plus

Cancer survivors report similar sexual activity, function as others their age

August 17, 2016
Sexual activity and function appeared no different in cancer survivors than in cancer-free adults aged 50 years or older, according to results of a…

Initiative fuels advancement, access of immuno-oncology in community setting

August 17, 2016
The approval and availability of new immunotherapy treatments sparked the need for dissemination of these therapies to patients throughout the cancer…

In the Journals Plus now live on Healio.com/HemOnc

August 17, 2016
Healio.com/HemOnc has launched In the Journals Plus, a new feature that will provide busy physicians with summaries of the top articles from leading…

In the Journals Plus

Most older breast cancer survivors maintain cognitive function

August 16, 2016
The majority of breast cancer survivors aged 65 years or older maintained good long-term self-reported cognitive function, according to the results…

More Headlines »
morganatic-roan
morganatic-roan